People ask about AOD-9604 results constantly, and the honest answer is: it works — just not the way most peptides get hyped online. You're not going to drop 20 lbs in 8 weeks. What you will see is stubborn fat coming off in areas that don't respond to diet or training — the kind of fat that sticks around even when you're doing everything right.
That's actually AOD-9604's specific niche. It's not a miracle weight loss drug. It's a precision tool for the last 5-10 lbs of fat that just won't move. Understanding what it does — and what it doesn't — is the difference between being disappointed with it and being genuinely impressed.
🔑 Key Takeaways
- AOD-9604 is a fragment of human growth hormone (amino acids 176-191) — it stimulates fat breakdown without raising IGF-1 or causing anabolic effects
- Realistic weight loss expectation: 2-6 lbs of pure fat over a 12-week cycle
- Works best at higher body fat % (18%+) — diminishing returns if you're already lean
- Fasting protocol matters significantly — inject on an empty stomach for best results
- AOD-9604 is not semaglutide. It's gentler, side-effect free, and targets fat specifically rather than suppressing appetite
What AOD-9604 Actually Does
AOD-9604 is a synthetic peptide fragment — specifically, positions 176-191 of human growth hormone (HGH). The "AOD" stands for Anti-Obesity Drug, which tells you exactly what it was designed for. Researchers at Monash University in Australia isolated this particular section of HGH and found something interesting: it retained the fat-mobilizing properties of full growth hormone without any of the growth-promoting effects.
The mechanism is direct. AOD-9604 binds to fat cell receptors and activates lipolysis — the breakdown of stored triglycerides into free fatty acids. Simultaneously, it inhibits lipogenesis, meaning it suppresses the formation of new fat. It's a two-pronged approach happening at the cellular level in adipose tissue.
What it does NOT do is equally important. Full HGH raises IGF-1 (insulin-like growth factor), which drives muscle and tissue growth and comes with a long list of potential issues at supraphysiological doses. AOD-9604 doesn't touch IGF-1. It has zero anabolic effect. It won't build muscle, affect bone density, or interfere with your endogenous hormone production. It's entirely targeted at fat metabolism.
This specificity is both its strength and its limitation. You want pure fat loss with minimal side effects? AOD-9604 delivers. You want the muscle fullness, recovery benefits, and skin effects of peptides like CJC-1295 or Ipamorelin? You'd need to stack those separately. For people who just want to lose fat — not bulk up, not optimize GH levels — the targeted mechanism is actually ideal.
For a deeper breakdown of the mechanism, dosing protocols, and stacking options, see our AOD-9604 complete guide.
AOD-9604 Before and After: Realistic Timeline
Here's the honest timeline based on consistent use at 300mcg/day, subcutaneous injection, fasted in the morning:
| Timeframe | What You'll Notice | What's Happening |
|---|---|---|
| Week 1–2 | Subtle appetite reduction in some users; slight energy shift | Peptide is establishing presence; lipolytic signaling begins |
| Week 3–4 | First visible changes in stubborn areas — lower abdomen, love handles | Active fat mobilization from problem areas; some users notice softer feel in subcutaneous fat |
| Week 6–8 | Clothes fitting differently; measurable reduction in body fat % | Consistent fat oxidation; improved definition in lower abs and flanks |
| Week 12 | Full results visible — 2–6 lbs pure fat lost, muscle fully preserved | Peak cumulative effect; optimal time to assess before deciding on another cycle |
Week 3–4 is usually when users get their first "wait, something is actually happening" moment. The lower abdomen is often the first place it shows. Not dramatic — but you'll notice. The flanks and love handles tend to follow a few weeks later.
Week 12 is about as far as a standard cycle runs. You can go longer, but the research data doesn't show significant additional benefit beyond 12 weeks at the standard dose. At this point, realistic outcomes for someone starting at ~20% body fat look like 3-5 lbs of pure fat loss — not weight loss with muscle included, actual fat tissue gone.
AOD-9604 Weight Loss Results: What the Research Says
The most relevant human data comes from a Phase 2b clinical trial run by Monash University — the same team that developed the peptide. At a 1mg/day dose over 12 weeks, subjects lost approximately 1kg of fat mass compared to placebo. Not groundbreaking by GLP-1 standards, but notable because it was pure fat loss with no muscle wasting and no significant adverse events.
A few things stand out in the data:
- Higher body fat % = better response. Subjects with more fat to lose showed significantly greater reductions than those who were already lean. The peptide needs fat to mobilize — if you're at 12% BF, there's not much to work with.
- Dose escalation above 1mg/day didn't improve results. The 1mg dose (roughly equivalent to 1000mcg/day) was optimal. Research peptide users typically work with 300mcg/day — lower than the clinical trial dose, which partially explains more modest results in practice.
- Fasting amplifies results significantly. The peptide's lipolytic mechanism is blunted in an insulin-elevated state. Pre-breakfast, fasted injection is consistently better than post-meal administration.
The fasting point deserves more attention than it usually gets. When you inject AOD-9604 after eating — especially after carbohydrates — elevated insulin essentially puts a lock on fat cells. The peptide is circulating, but the hormonal environment isn't receptive to fat release. Inject on a completely empty stomach, ideally after 10+ hours of fasting, and the response is noticeably better.
💡 Stacking for Better Results
AOD-9604 stacks well with MOTS-C (mitochondrial peptide that enhances energy expenditure and insulin sensitivity) and semaglutide (for users who want both appetite suppression and targeted fat mobilization). The MOTS-C + AOD-9604 combination is particularly interesting for metabolic optimization without the GI side effects of GLP-1s.
For the full dosage breakdown including stacking protocols, see our AOD-9604 dosage guide.
Before and After Profiles: 3 Real-World Examples
These profiles represent typical patterns — not outliers, not best-case scenarios. They're the kind of results that show up repeatedly in user reports when the protocol is followed correctly.
Profile 1: 38-Year-Old Male, 195 lbs, 22% Body Fat
Protocol: 12-week cycle, 300mcg/day, subcutaneous injection fasted every morning. Standard calorie maintenance diet. No other fat-loss peptides.
Results: Lost approximately 6 lbs of fat mass. DEXA scan showed body fat dropped from 22% to ~18.9%. Lean mass remained unchanged — in fact, slightly increased (likely measurement variation). Visually: ab definition appeared for the first time in years, flanks noticeably slimmer, face looked leaner.
What made this case interesting was the targeted nature of where fat came off. The upper chest and arms barely changed — those areas weren't particularly fat to begin with. The loss was concentrated in the abdomen and love handles. Classic AOD-9604 pattern.
Profile 2: 44-Year-Old Female, Post-Menopausal Belly Fat
Protocol: 8 weeks, 300mcg/day, fasted injection. Had been exercising 4x/week and eating at a moderate caloric deficit for 6+ months prior with minimal change in abdominal fat.
Results: Lost 4 lbs of abdominal fat over 8 weeks. The significance here is context — 6 months of diet and exercise had moved almost nothing in the belly. 8 weeks of AOD-9604 produced visible, measurable change in the same area. Post-menopausal fat redistribution is notoriously resistant to conventional approaches, and this is exactly the stubborn-fat application AOD-9604 is best suited for.
Profile 3: 29-Year-Old Male Athlete, 12% Body Fat, Cutting Phase
Protocol: 6-week cut, 300mcg/day AOD-9604 stacked with MOTS-C, aggressive caloric deficit, high training volume.
Results: Modest — roughly 1-2 lbs of additional fat loss beyond what the caloric deficit would predict. No muscle loss (expected on the stack). Definition improved, vascularity increased slightly.
This profile is important because it confirms what the clinical data suggests: when you're already lean, AOD-9604's impact is limited. At 12% body fat, there simply isn't much fat to mobilize. The peptide responds proportionally to available substrate. The athlete wasn't disappointed — he understood the mechanism going in — but it wasn't the transformation-level result that someone at 22% would experience.
Factors That Affect Your Results
This section matters because it explains why two people can run the identical protocol and see very different outcomes.
Starting Body Fat Percentage
Already covered above, but worth restating: this is the single biggest predictor of response. Users above 20% BF consistently report stronger results. Below 15%, results are modest. Below 12%, you're probably better off saving your money.
Fasting Protocol
Inject fasted. Every time. This isn't optional — it's the difference between the peptide working and not working optimally. Minimum 8-10 hours of fasting before injection. If you're doing 16:8 intermittent fasting, inject right before your eating window opens. Wait at least 20-30 minutes post-injection before eating.
Diet Quality
AOD-9604 amplifies fat burning — but it can't create a fat-burning environment if you're eating a caloric surplus. It's not a license to eat whatever you want. You don't need to be in an aggressive deficit, but maintenance or modest deficit is the minimum requirement. Eating at a 500-calorie surplus while running AOD-9604 will mostly just be an expensive experiment in futility.
Dosage
300mcg/day is the practical sweet spot based on both the clinical data and years of user reporting. Some protocols use 250mcg twice daily (500mcg total) for potentially enhanced effect, but the evidence that going above 300mcg/day improves outcomes is thin. The Phase 2b trial that showed the strongest results actually used 1mg/day — far higher than typical research peptide protocols. There's likely a dose-response relationship, but also diminishing returns.
Cycle Length
12 weeks is optimal. 6-week cycles show partial results — you'll see something, but you're cutting the process short before full adaptation and maximum fat mobilization occur. If budget is a constraint, a single proper 12-week cycle is better than two abbreviated ones.
AOD-9604 vs Semaglutide for Weight Loss
This comparison comes up a lot, and it deserves an honest answer rather than a sales pitch for either compound.
Semaglutide wins on raw weight loss numbers. Full stop. Clinical trials show 14-17% body weight reduction over 68 weeks. AOD-9604 produces 2-6 lbs of fat loss over 12 weeks. These aren't comparable interventions.
AOD-9604 wins on everything else:
| Factor | AOD-9604 | Semaglutide |
|---|---|---|
| Total fat loss | Modest (2–6 lbs/cycle) | Significant (15–20%+ body weight) |
| Side effects | Essentially none reported | Nausea, vomiting, GI disruption common |
| Muscle preservation | Excellent — no muscle loss | Some muscle loss (especially without resistance training) |
| Mechanism | Targeted fat cell lipolysis | Appetite suppression via GLP-1 receptor agonism |
| Cost | Lower | Higher (especially pharmaceutical forms) |
| Tolerance | High — most users have no complaints | Variable — some people can't tolerate GI effects |
The best use case for AOD-9604 is specifically people who want targeted fat loss without the GLP-1 side effect profile — nausea, vomiting, the general misery that some people experience on semaglutide, especially at higher doses. It's also compelling for people who are already fairly lean and want precision, not a nuclear option.
For people significantly overweight who need substantial total weight loss, semaglutide or retatrutide are the stronger tools. See our comparison: retatrutide vs semaglutide — which is right for you.
You can also stack them. AOD-9604 + semaglutide gives you both appetite suppression and direct fat mobilization. Anecdotally, the combination tends to amplify results beyond what either compound achieves alone — but that's a more advanced protocol worth discussing with someone familiar with your metabolic profile.